Latest Production News

CGN Resources has expanded its footprint in Western Australia's prolific gold belt by securing two new exploration licences near Leonora, enhancing its Panhandle Project and complementing the nearby Christmas Well Project. Initial drilling is slated for late 2025, targeting underexplored gold-bearing structures.

Altamin Limited has extended the closing date for its retail entitlement offer to 15 October 2025, aiming to raise up to AUD 6.46 million to support its mining projects.

Vault Minerals kicks off FY26 with robust gold sales and a fortified balance sheet, positioning itself for ambitious growth by FY28.

Amplitude Energy Limited has announced a proposed 11-for-1 share consolidation, pending shareholder approval at its upcoming AGM. This move aims to streamline its capital structure following a recent entitlement offer.

CONNEQT Health has disclosed significant revisions to its 2025 financial results, highlighting increased losses driven by a larger-than-expected fair value write-down on its inHealth investment and a heightened inventory provision.

BlackRock Investment Management (Australia) Limited has announced the estimated and confirmed distribution dates for 14 Australian domiciled iShares ETFs, outlining important deadlines for investors including the Distribution Reinvestment Plan opt-in and tax certification requirements.

Lakes Blue Energy reports strong gas shows and excellent reservoir quality from its Wombat-5 appraisal well in Victoria’s Gippsland Basin, setting the stage for imminent production testing and potential field development.

Advance Zintek reports a robust 26.83% revenue increase in Q1 FY26, driven by strong growth across North America, Australia, and Europe, despite regulatory hurdles impacting zinc oxide sales in Australia.

NexGen Energy has launched a dual equity offering, raising approximately C$400 million in North America and AUD 400 million in Australia to advance its flagship Rook I uranium project and support corporate growth.

Octava Minerals reports impressive bioleaching recoveries of critical minerals from its Byro project, prompting plans to acquire full ownership and expand exploration activities.

Arovella Therapeutics has demonstrated that its novel CLDN18.2 CAR-T cells effectively eliminate pancreatic cancer cells in vitro, matching the performance of a leading competitor’s product. The company is now advancing this CAR into its innovative iNKT cell platform to tackle solid tumours.

American Uranium Limited confirms the start of phase one resource drilling at its Lo Herma uranium project in the U.S. this October, aiming to grow its mineral resource and support a 2026 scoping study update.